Open-Conformation ADAMTS13 R1206K as a Next-Generation Therapeutic Candidate for TTP – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Szu-Mam Liu et al. published in JTH, adding:
“ADAMTS-13 R1206K Variant Exhibits an Open Conformation and an Enhanced Proteolytic Activity Toward von Willebrand Factor
The gain-of-function ADAMTS-13 R1206K variant demonstrates enhanced VWF cleavage, reduced autoantibody inhibition, and superior thrombus suppression under flow — offering a promising new therapeutic avenue for TTP.”
Title: ADAMTS-13 R1206K variant exhibits an open conformation and an enhanced proteolytic activity toward von Willebrand factor
Authors: Szumam Liu, Xiaxin Dong, Quintijn Bonnez, Zhirong Chai, Chan Meng, Madison Gil, Karen Vanhoorelbeke, Konstantine Halkidis, X. Long Zheng
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 2, 2026, 11:04Melissa Glasner: The Safe and Effective Implementation of FXI/XIa Inhibitors Into Clinical Practice
-
Jun 2, 2026, 10:55Claudio Laudani: Not All ”Bi-Risk” PCI Patients Are Equal
-
Jun 2, 2026, 10:45Erin VanDyke: Creating a Multidisciplinary Forum Where VTE Remains a Visible Institutional Priority Is What Matters
-
Jun 2, 2026, 10:40Eseosa Ighodaro: A Free Online Stroke Education Series Is Now Live
-
Jun 2, 2026, 10:35Dawn Carter: What Does an Acute Stroke Diagnosis Tell Us, If It Never Shows Up in Hospital Data?
-
Jun 2, 2026, 10:19Wolfgang Miesbach: Attitudes Towards Gene Therapy for Severe Haemophilia in Germany
-
Jun 1, 2026, 18:51Francesco Giurazza: New Publication on Glubran-2 in Acute Bleeding Patients with Coagulopathies
-
Jun 1, 2026, 18:50Donald Arnold is the Recipient of the Roberts Award – ISTH
-
Jun 1, 2026, 18:49Amirreza Jabbaripour Sarmadian: My First Paper as Corresponding Author on Upper Extremity DVT Following COVID-19 Vaccination